Citations (106)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (10)
Bo Feng, Jennnifer L LaPerle, George Chang & Manthena VS Varma. (2010) Renal clearance in drug discovery and development: molecular descriptors, drug transporters and disease state. Expert Opinion on Drug Metabolism & Toxicology 6:8, pages 939-952.
Read now
Read now
A.J. Scheen. (2008) MEDICATIONS IN THE KIDNEY. Acta Clinica Belgica 63:2, pages 76-80.
Read now
Read now
Meng Li, Gail D Anderson & Joanne Wang. (2006) Drugdrug interactions involving membrane transporters in the human kidney. Expert Opinion on Drug Metabolism & Toxicology 2:4, pages 505-532.
Read now
Read now
D. R. Taft, A. Dontabhaktuni, M. Babayeva, T. Nakatani-Freshwater & I. A. Savant. (2006) Application of the Isolated Perfused Rat Kidney Model to Assess Gender Effects on Drug Excretion. Drug Development and Industrial Pharmacy 32:8, pages 919-928.
Read now
Read now
Jasminder Sahi. (2005) Use of in vitro transporter assays to understand hepatic and renal disposition of new drug candidates. Expert Opinion on Drug Metabolism & Toxicology 1:3, pages 409-427.
Read now
Read now
T. Minematsu, K.-Y. Sohda, T. Hashimoto, H. Imai, T. Usui & H. Kamimura. (2005) Identification of metabolites of [14C]zonampanel, an α-amino-3-hydroxy-5-methylisoxazole-4-propionate receptor antagonist, following intravenous infusion in healthy volunteers. Xenobiotica 35:4, pages 359-371.
Read now
Read now
Evelyn O'Brien & Daniel R. Dietrich. (2005) Ochratoxin A: The Continuing Enigma. Critical Reviews in Toxicology 35:1, pages 33-60.
Read now
Read now
DanielR. Dietrich, Alexandra H. Heussner & Evelyn O’Brien. (2005) Ochratoxin A: Comparative pharmacokinetics and toxicological implications (experimental and domestic animals and humans). Food Additives & Contaminants 22:sup1, pages 45-52.
Read now
Read now
Xing Han, Paul M. Hinderliter, Timothy A. Snow & Gary W. Jepson. (2004) Binding of Perfluorooctanoic Acid to Rat Liver‐form and Kidney‐form α2u‐Globulins . Drug and Chemical Toxicology 27:4, pages 341-360.
Read now
Read now
T. Prueksaritanont, J. H. Hochman, Y. Meng, N. T. Pudvah, A. Barrish, B. Ma, M. Yamazaki, C. Fernandez-metzler & J. H. Lin. (2004) Renal elimination of a novel and potent αvβ3 integrin antagonist in animals. Xenobiotica 34:11-12, pages 1059-1074.
Read now
Read now
Articles from other publishers (96)
Courtney Sakolish, Haley L Moyer, Han-Hsuan D Tsai, Lucie C Ford, Allison N Dickey, Fred A Wright, Gang Han, Piyush Bajaj, Maria T Baltazar, Paul L Carmichael, Jason P Stanko, Stephen S Ferguson & Ivan Rusyn. (2023)
Analysis of reproducibility and robustness of a renal proximal tubule microphysiological system OrganoPlate 3-lane 40 for
in vitro
studies of drug transport and toxicity
. Toxicological Sciences 196:1, pages 52-70.
Crossref
Crossref
Wei Chen, Bing Wang, Shanshan Liang, Meng Wang, Lingna Zheng, Si Xu, Jiali Wang, Hao Fang, Pu Yang & Weiyue Feng. (2023) Renal clearance of graphene oxide: glomerular filtration or tubular secretion and selective kidney injury association with its lateral dimension. Journal of Nanobiotechnology 21:1.
Crossref
Crossref
Kate A. Wickham & Lawrence L. Spriet. (2023) Food for thought: Physiological considerations for nutritional ergogenic efficacy. Scandinavian Journal of Medicine & Science in Sports.
Crossref
Crossref
Michael L. Behal, Alexander H. Flannery & Erin F. Barreto. (2023) Medication Management in the Critically Ill Patient with Acute Kidney Injury. Clinical Journal of the American Society of Nephrology.
Crossref
Crossref
Diandra Nunes Barreto, Josiele Aparecida Magalhães Conrado, Rafaela Silva Lamarca, Alex Domingues Batista, Arnaldo Alves Cardoso, Paulo Clairmont F. de Lima Gomes & João Flávio da Silveira Petruci. 2023. Encyclopedia of Sensors and Biosensors. Encyclopedia of Sensors and Biosensors
560
576
.
Joseph L. Jilek, Kayla L. Frost, Solène Marie, Cassandra M. Myers, Michael Goedken, Stephen H. Wright & Nathan J. Cherrington. (2022) Attenuated Ochratoxin A Transporter Expression in a Mouse Model of Nonalcoholic Steatohepatitis Protects against Proximal Convoluted Tubule Toxicity. Drug Metabolism and Disposition 50:10, pages 1389-1395.
Crossref
Crossref
Jagannath Mondal, Jeong Man An, Sachin S. Surwase, Kushal Chakraborty, Sabuj Chandra Sutradhar, Joon Hwang, Jaewook Lee & Yong-Kyu Lee. (2022) Carbon Nanotube and Its Derived Nanomaterials Based High Performance Biosensing Platform. Biosensors 12:9, pages 731.
Crossref
Crossref
Mai Hashimoto, Hitoshi Maeda, Kentaro Oniki, Norio Yasui-Furukori, Hiroshi Watanabe, Junji Saruwatari & Daisuke Kadowaki. (2022) New Insight Concerning Therapeutic Drug Monitoring—The Importance of the Concept of Psychonephrology—. Biological and Pharmaceutical Bulletin 45:7, pages 834-842.
Crossref
Crossref
Íris Guerreiro, Cíntia Ferreira-Pêgo, Diogo Carregosa, Cláudia N. Santos, Regina Menezes, Ana S. Fernandes & João G. Costa. (2022) Polyphenols and Their Metabolites in Renal Diseases: An Overview. Foods 11:7, pages 1060.
Crossref
Crossref
Manthena V. S. Varma, Ayman El‐Kattan & Yurong Lai. 2022. Drug Transporters. Drug Transporters
433
452
.
Simone Q. Pantaleão, Philipe O. Fernandes, José Eduardo Gonçalves, Vinícius G. Maltarollo & Kathia Maria Honorio. (2021) Recent Advances in the Prediction of Pharmacokinetics Properties in Drug Design Studies: A Review. ChemMedChem 17:1.
Crossref
Crossref
Erin F. Barreto, Thomas R. Larson & Emily J. Koubek. 2022. Comprehensive Pharmacology. Comprehensive Pharmacology
627
644
.
Alan Talevi & Carolina L. Bellera. 2022. The ADME Encyclopedia. The ADME Encyclopedia
1059
1065
.
Alan Talevi & Carolina L. Bellera. 2021. The ADME Encyclopedia. The ADME Encyclopedia
1
7
.
Shruti Chillistone & Jonathan G. Hardman. (2020) Modes of drug elimination and bioactive metabolites. Anaesthesia & Intensive Care Medicine 21:9, pages 474-477.
Crossref
Crossref
Lenka Stroobant, Siska Croubels, Laura Dhondt, Joske Millecam, Siegrid De Baere, Elke Gasthuys, Joachim Morrens & Gunther Antonissen. (2020) Simultaneous Measurement of Glomerular Filtration Rate, Effective Renal Plasma Flow and Tubular Secretion in Different Poultry Species by Single Intravenous Bolus of Iohexol and Para-Aminohippuric Acid. Animals 10:6, pages 1027.
Crossref
Crossref
Marie-Laure Boof, Atef Halabi, Mike Ufer & Jasper Dingemanse. (2019) Impact of the organic cation transporter 2 inhibitor cimetidine on the single-dose pharmacokinetics of the glucosylceramide synthase inhibitor lucerastat in healthy subjects. European Journal of Clinical Pharmacology 76:3, pages 431-437.
Crossref
Crossref
Askhi M. Valodara & Kaid Johar SR. (2020) Sexual Dimorphism in Drug Metabolism and Pharmacokinetics. Current Drug Metabolism 20:14, pages 1154-1166.
Crossref
Crossref
Jianhui Chen, Hongbin Yang, Lan Zhu, Zengrui Wu, Weihua Li, Yun Tang & Guixia Liu. (2020)
In Silico
Prediction of Human Renal Clearance of Compounds Using Quantitative Structure-Pharmacokinetic Relationship Models
. Chemical Research in Toxicology 33:2, pages 640-650.
Crossref
Crossref
Nicoleta Vedeanu, Cezara Voica, Dana Alina Magdas, Bela Kiss, Maria-Georgia Stefan, Ramona Simedrea, Carmen Georgiu, Cristian Berce, Oliviu Vostinaru, Rodica Boros, Ionel Fizesan, Marius Emil Rusu, Adriana Grozav, Felicia Loghin & Daniela-Saveta Popa. (2020) Subacute co-exposure to low doses of ruthenium(III) changes the distribution, excretion and biological effects of silver ions in rats. Environmental Chemistry 17:2, pages 163.
Crossref
Crossref
Christopher Ruark. 2020. Physiologically Based Pharmacokinetic (PBPK) Modeling. Physiologically Based Pharmacokinetic (PBPK) Modeling
139
160
.
Jihwan Son, Gawon Yi, Moon-Hwa Kwak, Seung Mok Yang, Jae Myung Park, Bo-In Lee, Myung-Gyu Choi & Heebeom Koo. (2019) Gelatin–chlorin e6 conjugate for in vivo photodynamic therapy. Journal of Nanobiotechnology 17:1.
Crossref
Crossref
DeAnn Liska, Eunice Mah, Tristin Brisbois, Pamela L. Barrios, Lindsay B. Baker & Lawrence L. Spriet. (2019) Narrative Review of Hydration and Selected Health Outcomes in the General Population. Nutrients 11:1, pages 70.
Crossref
Crossref
Jafna L. Cox. (2018) Renal Function Estimation Equations and Drug Dosing: Things Are Not Always What They Seem. Canadian Journal of Cardiology 34:8, pages 965-967.
Crossref
Crossref
Jun Gi Rho, Hwa Seung Han, Ji Hye Han, Hansang Lee, Van Quy Nguyen, Wang Hee Lee, Seunglee Kwon, Sungeun Heo, Juhwan Yoon, Han Ho Shin, Eun-young Lee, Hoin Kang, Siyoung Yang, Eun Kyung Lee, Jae Hyung Park & Wook Kim. (2018) Self-assembled hyaluronic acid nanoparticles: Implications as a nanomedicine for treatment of type 2 diabetes. Journal of Controlled Release 279, pages 89-98.
Crossref
Crossref
Ayman F. El-Kattan & Manthena V. S. Varma. (2018) Navigating Transporter Sciences in Pharmacokinetics Characterization Using the Extended Clearance Classification System. Drug Metabolism and Disposition 46:5, pages 729-739.
Crossref
Crossref
Fangfang Xia, Wenxiu Hou, Chunlei Zhang, Xiao Zhi, Jin Cheng, Jesús M. de la Fuente, Jie Song & Daxiang Cui. (2018) pH-responsive gold nanoclusters-based nanoprobes for lung cancer targeted near-infrared fluorescence imaging and chemo-photodynamic therapy. Acta Biomaterialia 68, pages 308-319.
Crossref
Crossref
Manjunath P. Pai, Jennifer J. Kiser, Paul O. Gubbins & Keith A. Rodvold. 2018. Drug Interactions in Infectious Diseases: Mechanisms and Models of Drug Interactions. Drug Interactions in Infectious Diseases: Mechanisms and Models of Drug Interactions
1
13
.
Max Taubert, Joseph Chiesa, Mark Lückermann, Carsten Fischer, Axel Dalhoff & Uwe Fuhr. (2017) Pharmacokinetics of Intravenous Finafloxacin in Healthy Volunteers. Antimicrobial Agents and Chemotherapy 61:10.
Crossref
Crossref
Shruti Chillistone & Jonathan G. Hardman. (2017) Modes of drug elimination and bioactive metabolites. Anaesthesia & Intensive Care Medicine 18:9, pages 458-461.
Crossref
Crossref
Manthena V. Varma, Yurong Lai & Ayman F. El-Kattan. (2017) Molecular properties associated with transporter-mediated drug disposition. Advanced Drug Delivery Reviews 116, pages 92-99.
Crossref
Crossref
Ayman F. El‐Kattan. 2017. Oral Bioavailability Assessment. Oral Bioavailability Assessment
309
329
.
Ayman F. El‐Kattan. 2017. Oral Bioavailability Assessment. Oral Bioavailability Assessment
77
138
.
Jia Yin, Haichuan Duan & Joanne Wang. (2016) Impact of Substrate-Dependent Inhibition on Renal Organic Cation Transporters hOCT2 and hMATE1/2-K-Mediated Drug Transport and Intracellular Accumulation. Journal of Pharmacology and Experimental Therapeutics 359:3, pages 401-410.
Crossref
Crossref
Jia Yin & Joanne Wang. (2016) Renal drug transporters and their significance in drug–drug interactions. Acta Pharmaceutica Sinica B 6:5, pages 363-373.
Crossref
Crossref
Bo Feng & Manthena V. Varma. (2016) Evaluation and Quantitative Prediction of Renal Transporter-Mediated Drug-Drug Interactions. The Journal of Clinical Pharmacology 56, pages S110-S121.
Crossref
Crossref
Rutwij A. Dave & Marilyn E. Morris. (2016) A quantitative threshold for high/low extent of urinary excretion of compounds in humans. Biopharmaceutics & Drug Disposition 37:5, pages 287-309.
Crossref
Crossref
Hwa Seung Han, Minchang Lee, Jae Yoon An, Soyoung Son, Hyewon Ko, Hansang Lee, Yee Soo Chae, Young Mo Kang & Jae Hyung Park. (2015) A pH‐responsive carboxymethyl dextran‐based conjugate as a carrier of docetaxel for cancer therapy. Journal of Biomedical Materials Research Part B: Applied Biomaterials 104:4, pages 789-796.
Crossref
Crossref
J. Q. Dong, M. V. Varma, A. Wolford, T. Ryder, L. Di, B. Feng, S. G. Terra, K. Sagawa & A. S. Kalgutkar. (2015) Pharmacokinetics and Disposition of the Thiouracil Derivative PF-06282999, an Orally Bioavailable, Irreversible Inactivator of Myeloperoxidase Enzyme, Across Animals and Humans. Drug Metabolism and Disposition 44:2, pages 209-219.
Crossref
Crossref
Odilia Osakwe. 2016. Social Aspects of Drug Discovery, Development and Commercialization. Social Aspects of Drug Discovery, Development and Commercialization
129
148
.
Li Di & Edward H. Kerns. 2016. Drug-Like Properties. Drug-Like Properties
113
140
.
Manthena V. Varma, Stefanus J. Steyn, Charlotte Allerton & Ayman F. El-Kattan. (2015) Predicting Clearance Mechanism in Drug Discovery: Extended Clearance Classification System (ECCS). Pharmaceutical Research 32:12, pages 3785-3802.
Crossref
Crossref
Marie Volková, Jana Mandíková, Pavel Bárta, Lucie Navrátilová, Alice Lázníčková & František Trejtnar. (2015)
The
in vivo
disposition and
in vitro
transmembrane transport of two model radiometabolites of DOTA-conjugated receptor-specific peptides labelled with
177
Lu
. Journal of Labelled Compounds and Radiopharmaceuticals 58:13-14, pages 483-489.
Crossref
Crossref
Souzan B. Yanni. 2015. Translational ADMET for Drug Therapy. Translational ADMET for Drug Therapy
111
138
.
Hyuk-Sang Jeong, In-geun Ryoo & Mi-Kyoung Kwak. (2015) Regulation of the expression of renal drug transporters in KEAP1-knockdown human tubular cells. Toxicology in Vitro 29:5, pages 884-892.
Crossref
Crossref
Carolien Schophuizen, Joost Hoenderop, Rosalinde Masereeuw & Lambert Heuvel. (2015) Uremic Toxins Induce ET-1 Release by Human Proximal Tubule Cells, which Regulates Organic Cation Uptake Time-Dependently. Cells 4:3, pages 234-252.
Crossref
Crossref
Violeta Rodr?guez-Romero, Karla I. Gonz?lez-Villalva, Jos? L. Reyes, Rebecca E. Franco-Bourland, Gabriel Gu?zar-Sahag?n, Gilberto Casta?eda-Hern?ndez & Leticia Cruz-Antonio. (2015) A novel, simple and inexpensive procedure for the simultaneous determination of iopamidol and p-aminohippuric acid for renal function assessment from plasma samples in awake rats. Journal of Pharmaceutical and Biomedical Analysis 107, pages 196-203.
Crossref
Crossref
Hwa Seung Han, Thavasyappan Thambi, Ki Young Choi, Soyoung Son, Hyewon Ko, Min Chang Lee, Dong-Gyu Jo, Yee Soo Chae, Young Mo Kang, Jun Young Lee & Jae Hyung Park. (2015) Bioreducible Shell-Cross-Linked Hyaluronic Acid Nanoparticles for Tumor-Targeted Drug Delivery. Biomacromolecules 16:2, pages 447-456.
Crossref
Crossref
Rutwij A. Dave & Marilyn E. Morris. (2015) Quantitative Structure-Pharmacokinetic Relationships for the Prediction of Renal Clearance in Humans. Drug Metabolism and Disposition 43:1, pages 73-81.
Crossref
Crossref
Ayman El‐Kattan, Manthena V. Varma & Yurong Lai. 2014. Drug Transporters. Drug Transporters
371
387
.
Shruti Chillistone & Jonathan G. Hardman. (2014) Modes of drug elimination and bioactive metabolites. Anaesthesia & Intensive Care Medicine 15:8, pages 388-391.
Crossref
Crossref
Annett Kunze, Jörg Huwyler, Birk Poller, Heike Gutmann & Gian Camenisch. (2014) In Vitro–In Vivo Extrapolation Method to Predict Human Renal Clearance of Drugs. Journal of Pharmaceutical Sciences 103:3, pages 994-1001.
Crossref
Crossref
Li Di, Bo Feng, Theunis C. Goosen, Yurong Lai, Stefanus J. Steyn, Manthena V. Varma & R. Scott Obach. (2013) A Perspective on the Prediction of Drug Pharmacokinetics and Disposition in Drug Research and Development. Drug Metabolism and Disposition 41:12, pages 1975-1993.
Crossref
Crossref
Bo Feng, Susan Hurst, Yasong Lu, Manthena V. Varma, Charles J. Rotter, Ayman El-Kattan, Peter Lockwood & Brian Corrigan. (2013) Quantitative Prediction of Renal Transporter-Mediated Clinical Drug–Drug Interactions. Molecular Pharmaceutics 10:11, pages 4207-4215.
Crossref
Crossref
Frans G. M. Russel & Rosalinde Masereeuw. 2013. Transporters in Drug Development. Transporters in Drug Development
235
256
.
Bo Feng, Ayman F. El‐Kattan & Zaher A. Radi. (2012) Renal Transporters in Drug Disposition, Drug‐Drug Interactions, and Nephrotoxicity. Current Protocols in Toxicology 53:1.
Crossref
Crossref
Alexander V. LyubimovRonald E. Savage. 2011. Encyclopedia of Drug Metabolism and Interactions. Encyclopedia of Drug Metabolism and Interactions
1
38
.
Manthena V. Varma, Iain GardnerStefanus J. Steyn, Paul Nkansah, Charles J. Rotter, Carrie Whitney-Pickett, Hui Zhang, Li Di, Michael CramKatherine S. FennerAyman F. El-Kattan. (2012) pH-Dependent Solubility and Permeability Criteria for Provisional Biopharmaceutics Classification (BCS and BDDCS) in Early Drug Discovery. Molecular Pharmaceutics 9:5, pages 1199-1212.
Crossref
Crossref
Hong Yeol Yoon, Heebeom Koo, Ki Young Choi, So Jin Lee, Kwangmeyung Kim, Ick Chan Kwon, James F. Leary, Kinam Park, Soon Hong Yuk, Jae Hyung Park & Kuiwon Choi. (2012) Tumor-targeting hyaluronic acid nanoparticles for photodynamic imaging and therapy. Biomaterials 33:15, pages 3980-3989.
Crossref
Crossref
Sheila Annie Peters. 2012. Physiologically‐Based Pharmacokinetic (PBPK) Modeling and Simulations. Physiologically‐Based Pharmacokinetic (PBPK) Modeling and Simulations
183
207
.
Arthur J. AtkinsonJr.Jr. & Juan J.L. Lertora. 2012. Principles of Clinical Pharmacology. Principles of Clinical Pharmacology
55
64
.
Pankaj Gupta, Bo Feng & Jack Cook. 2011. Oral Bioavailability. Oral Bioavailability
167
182
.
Shruti Chillistone & Jonathan G. Hardman. (2011) Modes of drug elimination and bioactive metabolites. Anaesthesia & Intensive Care Medicine 12:8, pages 371-374.
Crossref
Crossref
Hélène M. Faessel, R. Scott Obach, Hans Rollema, Patanjali Ravva, Kathryn E. Williams & Aaron H. Burstein. (2010) A Review of the Clinical Pharmacokinetics and Pharmacodynamics of Varenicline for Smoking Cessation. Clinical Pharmacokinetics 49:12, pages 799-816.
Crossref
Crossref
Urban Fagerholm. (2007) Prediction of human pharmacokinetics — renal metabolic and excretion clearance. Journal of Pharmacy and Pharmacology 59:11, pages 1463-1471.
Crossref
Crossref
Cornelia B. Landersdorfer, Carl M. J. Kirkpatrick, Martina Kinzig, Jürgen B. Bulitta, Ulrike Holzgrabe, Ulrich Jaehde, Andreas Reiter, Kurt G. Naber, Michael Rodamer & Fritz Sörgel. (2010) Competitive inhibition of renal tubular secretion of ciprofloxacin and metabolite by probenecid. British Journal of Clinical Pharmacology 69:2, pages 167-178.
Crossref
Crossref
Cristina Rodríguez-Antona & Julia Kirchheiner. 2010. Pharmacogenetics: Making cancer treatment safer and more effective. Pharmacogenetics: Making cancer treatment safer and more effective
11
26
.
Frans G.M. Russel. 2010. Enzyme- and Transporter-Based Drug-Drug Interactions. Enzyme- and Transporter-Based Drug-Drug Interactions
27
49
.
Manthena V. S. Varma, Bo Feng, R. Scott Obach, Matthew D. Troutman, Jonathan Chupka, Howard R. Miller & Ayman El-Kattan. (2009) Physicochemical Determinants of Human Renal Clearance. Journal of Medicinal Chemistry 52:15, pages 4844-4852.
Crossref
Crossref
Li Xia, Mingyan Zhou, Thomas F. Kalhorn, Horace T. B. Ho & Joanne Wang. (2009) Podocyte-specific expression of organic cation transporter PMAT: implication in puromycin aminonucleoside nephrotoxicity. American Journal of Physiology-Renal Physiology 296:6, pages F1307-F1313.
Crossref
Crossref
Stefan Balaz. (2009) Modeling Kinetics of Subcellular Disposition of Chemicals. Chemical Reviews 109:5, pages 1793-1899.
Crossref
Crossref
. 2009. Animal Clinical Chemistry. Animal Clinical Chemistry
67
96
.
Hongliang Cai, Arun K. Agrawal, David A. Putt, Muhammed Hashim, Anita Reddy, Joanne Brodfuehrer, Narayanan Surendran & Lawrence H. Lash. (2009) Assessment of the renal toxicity of novel anti-inflammatory compounds using cynomolgus monkey and human kidney cells. Toxicology 258:1, pages 56-63.
Crossref
Crossref
Hiroyuki Kusuhara & Yuichi Sugiyama. (2009) In vitro-in vivo Extrapolation of Transporter-mediated Clearance in the Liver and Kidney. Drug Metabolism and Pharmacokinetics 24:1, pages 37-52.
Crossref
Crossref
David R. Taft. 2009. Pharmacology. Pharmacology
175
199
.
Cornelia B. Landersdorfer, Carl M. J. Kirkpatrick, Martina Kinzig, Jürgen B. Bulitta, Ulrike Holzgrabe & Fritz Sörgel. (2008) Inhibition of flucloxacillin tubular renal secretion by piperacillin. British Journal of Clinical Pharmacology 66:5, pages 648-659.
Crossref
Crossref
Jonathan N. Wilkinson, Iain K. Moppett & Jonathan G. Hardman. (2008) Modes of drug elimination. Anaesthesia & Intensive Care Medicine 9:8, pages 362-365.
Crossref
Crossref
B Feng, RS Obach, AH Burstein, DJ Clark, SM de Morais & HM Faessel. (2007) Effect of Human Renal Cationic Transporter Inhibition on the Pharmacokinetics of Varenicline, a New Therapy for Smoking Cessation: An In Vitro–In Vivo Study. Clinical Pharmacology & Therapeutics 83:4, pages 567-576.
Crossref
Crossref
Suzanne Heemskerk, Alfons C. Wouterse, Frans G.M. Russel & Rosalinde Masereeuw. (2008) Nitric oxide down-regulates the expression of organic cation transporters (OCT) 1 and 2 in rat kidney during endotoxemia. European Journal of Pharmacology 584:2-3, pages 390-397.
Crossref
Crossref
Urban Fagerholm. (2007) The Role of Permeability in Drug ADME/PK, Interactions and Toxicity—Presentation of a Permeability-Based Classification System (PCS) for Prediction of ADME/PK in Humans. Pharmaceutical Research 25:3, pages 625-638.
Crossref
Crossref
Suzanne Heemskerk, Frank M. P. van Haren, Norbert A. Foudraine, Wilbert H. M. Peters, Johannes G. van der Hoeven, Frans G. M. Russel, Rosalinde Masereeuw & Peter Pickkers. (2007) Short-term beneficial effects of methylene blue on kidney damage in septic shock patients. Intensive Care Medicine 34:2, pages 350-354.
Crossref
Crossref
Ramiro E. Toribio. (2007) Essentials of Equine Renal and Urinary Tract Physiology. Veterinary Clinics of North America: Equine Practice 23:3, pages 533-561.
Crossref
Crossref
Johannes Kornhuber, Evelin M Kennepohl, Stefan Bleich, Jens Wiltfang, Thomas Kraus, Udo Reulbach & Ingolf Meineke. (2007) Memantine Pharmacotherapy. Clinical Pharmacokinetics 46:7, pages 599-612.
Crossref
Crossref
Takahiro Shibayama, Daisuke Sugiyama, Emi Kamiyama, Taro Tokui, Takashi Hirota & Toshihiko Ikeda. (2007) Characterization of CS-023 (RO4908463), a Novel Parenteral Carbapenem Antibiotic, and Meropenem as Substrates of Human Renal Transporters. Drug Metabolism and Pharmacokinetics 22:1, pages 41-47.
Crossref
Crossref
Daniel Kapusta. 2007. xPharm: The Comprehensive Pharmacology Reference. xPharm: The Comprehensive Pharmacology Reference
1
5
.
Joseph Meletiadis, Stephen Chanock & Thomas J. Walsh. (2006) Human Pharmacogenomic Variations and Their Implications for Antifungal Efficacy. Clinical Microbiology Reviews 19:4, pages 763-787.
Crossref
Crossref
Maria Maniscalco, Devada Singh-Franco, William R. Wolowich & Rolando Torres-Colón. (2006) Solifenacin succinate for the treatment of symptoms of overactive bladder. Clinical Therapeutics 28:9, pages 1247-1272.
Crossref
Crossref
Akinsan Dosekun, John Foringer & Bruce Kone. 2006. Modern Surgical Care. Modern Surgical Care
725
765
.
Mark A. Perazella & Chirag Parikh. (2005) Pharmacology. American Journal of Kidney Diseases 46:6, pages 1129-1139.
Crossref
Crossref
Jens Rengelshausen, J�rgen Burhenne, Margit Fr�hlich, Yorki Tayrouz, Shio Kumar Singh, Klaus-Dieter Riedel, Olaf M�ller, Torsten Hoppe-Tichy, Walter E. Haefeli, Gerd Mikus & Ingeborg Walter-Sack. (2004) Pharmacokinetic interaction of chloroquine and methylene blue combination against malaria. European Journal of Clinical Pharmacology 60:10, pages 709-715.
Crossref
Crossref
Guofeng You. (2004) Towards an understanding of organic anion transporters: Structure–function relationships. Medicinal Research Reviews 24:6, pages 762-774.
Crossref
Crossref
Varsha G. Desai, Carrie L. Moland, William S. Branham, Robert R. Delongchamp, Hong Fang, Peter H. Duffy, Charlotte A. Peterson, Marjorie L. Beggs & James C. Fuscoe. (2004) Changes in expression level of genes as a function of time of day in the liver of rats. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 549:1-2, pages 115-129.
Crossref
Crossref
Wooin LeeRichard B. Kim. (2004) Transporters and Renal Drug Elimination. Annual Review of Pharmacology and Toxicology 44:1, pages 137-166.
Crossref
Crossref
Rosalinde Masereeuw, Sylvia Notenboom, Pascal H. E. Smeets, Alfons C. Wouterse & Frans G. M. Russel. (2003)
Impaired Renal Secretion of Substrates for the Multidrug Resistance Protein 2 in Mutant Transport–Deficient (TR
−
) Rats
. Journal of the American Society of Nephrology 14:11, pages 2741-2749.
Crossref
Crossref
Naomi Mizuno, Takuro Niwa, Yoshihisa Yotsumoto & Yuichi Sugiyama. (2003) Impact of Drug Transporter Studies on Drug Discovery and Development. Pharmacological Reviews 55:3, pages 425-461.
Crossref
Crossref
Sylvie A. Terlouw, Rosalinde Masereeuw & Frans G.M. Russel. (2003) Modulatory effects of hormones, drugs, and toxic events on renal organic anion transport. Biochemical Pharmacology 65:9, pages 1393-1405.
Crossref
Crossref